Jens Werner

Active 1993–2025

213
Papers
24,015
Citations
89
h-index
185
i10-index

Citations

Citations per year for Jens Werner1986: 1 citations1997: 1 citations1998: 3 citations1999: 6 citations2000: 5 citations2001: 11 citations2002: 16 citations2003: 24 citations2004: 28 citations2005: 36 citations2006: 54 citations2007: 43 citations2008: 31 citations2009: 40 citations2010: 58 citations2011: 47 citations2012: 111 citations2013: 131 citations2014: 176 citations2015: 169 citations2016: 178 citations2017: 186 citations2018: 174 citations2019: 721 citations2020: 960 citations2021: 979 citations2022: 753 citations2023: 587 citations2024: 1,026 citations2025: 560 citations2026: 29 citations1987–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,831 citing papers, 18.2% of this breakdownChina: 1,736 citing papers, 17.3% of this breakdownGermany: 949 citing papers, 9.4% of this breakdownItaly: 571 citing papers, 5.7% of this breakdownUnited Kingdom: 485 citing papers, 4.8% of this breakdownNetherlands: 335 citing papers, 3.3% of this breakdownJapan: 310 citing papers, 3.1% of this breakdownFrance: 285 citing papers, 2.8% of this breakdownSpain: 242 citing papers, 2.4% of this breakdownCanada: 227 citing papers, 2.3% of this breakdownIndia: 223 citing papers, 2.2% of this breakdownSweden: 199 citing papers, 2% of this breakdown
0%18.2%Other 26.5%

Fields

  • Medicine67.7%
  • Biochemistry, Genetics and Molecular Biology19.4%
  • Immunology and Microbiology6.4%
  • Neuroscience1.5%
  • Engineering1.5%
  • Agricultural and Biological Sciences0.5%
  • Other3%

Topics

  • Pancreatic and Hepatic Oncology Research11.4%
  • Pancreatitis Pathology and Treatment7.7%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Gallbladder and Bile Duct Disorders2.2%
  • Cancer Cells and Metastasis2.1%
  • Neuroendocrine Tumor Research Advances1.8%
  • Other72.1%

Coauthors

All papers

Open in search
  1. Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy

    Authors: , , , , , , - Journal of Cellular Physiology 2016 cited by 688

  2. β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2017 cited by 506

  3. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases

    Authors: , , , , , , , , , , , - Journal of Gastrointestinal Surgery 2021 cited by 257

  4. Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 336

  5. Advances in cancer immunotherapy 2019 – latest trends

    Authors: , , , , , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2019 cited by 588

  6. Chronic pancreatitis

    Authors: , , , , - The Lancet 2020 cited by 484

  7. Reactive Oxygen Species in the Immune System

    Authors: , , , - International Reviews of Immunology 2013 cited by 507

  8. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Research 2016 cited by 419

  9. Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2021 cited by 174

  10. Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread

    Authors: , , , , , , , - Journal of Oncology 2019 cited by 299

  11. United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - United European Gastroenterology Journal 2017 cited by 698

  12. Reactive oxygen species and colorectal cancer

    Authors: , , , , - Journal of Cellular Physiology 2017 cited by 161

  13. Prevailing Role of Contact Guidance in Intrastromal T-cell Trapping in Human Pancreatic Cancer

    Authors: , , , , , , - Clinical Cancer Research 2014 cited by 244

  14. Cancer Vaccines: Antigen Selection Strategy

    Authors: , , , , , - Vaccines 2021 cited by 80

  15. Myeloid-Derived Suppressor Cells in Solid Tumors

    Authors: , , , , , , - Cells 2022 cited by 107

  16. Postpancreatectomy Acute Pancreatitis (PPAP)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ioannis Passas, Luca Gianotti, Marco Del Chiaro, Richard D. Schulick, Marco Montorsi, Attila Oláh, Giuseppe Fusai, Alejandro Serrablo, Alessandro Zerbi, Abe Fingerhut, Roland Andersson, Robert Padbury, Christos Dervenis, John P. Neoptolemos, Claudio Bassi, Markus W. Büchler, Shailesh V. Shrikhande, on behalf of the International Study Group for Pancreatic Surgery - Annals of Surgery 2021 cited by 155

  17. CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy

    Authors: , , , , , , , - Annals of Surgical Oncology 2012 cited by 297

  18. Neutrophil extracellular traps facilitate cancer metastasis: cellular mechanisms and therapeutic strategies

    Authors: , , , , , - Journal of Cancer Research and Clinical Oncology 2022 cited by 47

  19. A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Surgery 2021 cited by 230

  20. Gut Barrier Dysfunction and Bacterial Lipopolysaccharides in Colorectal Cancer

    Authors: , , , , , , , , - Journal of Gastrointestinal Surgery 2023 cited by 61

  21. Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Grimminger, Florian Lordick - New England Journal of Medicine 2025 cited by 235

  22. CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 cited by 227

  23. Improvement of surgical results for pancreatic cancer

    Authors: , , , , - The Lancet Oncology 2013 cited by 373

  24. Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandra Kunz, Evelin Hund, Ronald Limprecht, Hans J. Schlitt, Joachim Mössner, Christoph M. Seiler, Gabriele Ihorst, Pierluigi Di Sebastiano, Helmut Witzigmann, Fritz Klein, Heike Berthold, Heike Körnlein, Ulrich T. Hopt, Olivia Sick, Tobias Keck, Lars Ivo Partecke, Sebastian Peters, Markus M. Lerch, Barbara Maichle, Birgit Erni, Sabine Bunjes-Schmieger, Sarah Igel, Svenja Stemmle, John P. Neoptolemos, Michael Raraty, Miha Petrič, Marco Niedergethmann, Claudia Schwarzmeier, Bernhard W. Renz, Brigitte Schreib, Wolfgang E. Thasler, M. H. Schoenberg, Helmut Frieß, Daniel Reim, Güralp O. Ceyhan, Monika Diehl-Bein, Thomas Simon, Tobias Gehrig, Marion Hoffer, Christoph T. Germer - The Lancet 2017 cited by 171